2m 2m 2m 2m 2m 2m 2m
Prothena Corp (PRTA)
NASDAQ
$8.86-$0.33 (-3.58%)
Price as of Jun 03, 2026 4:22 PM EDT- $533.0MMarket Cap
- 90.27%1-Year Change
- BiotechnologyIndustry
Prothena Corp (PRTA)
$8.86-$0.33 (-3.58%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.6M -92.87% | 135.2M +47.92% | 91.4M +69.50% | 53.9M -73.13% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 9.6M -92.87% | 135.2M +47.92% | 91.4M +69.50% | 53.9M -73.13% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -134.9M -39.40% | -222.5M +0.88% | -220.6M +62.71% | -135.6M +64.75% | |
Depreciation and Amortization Expense | 895,000 +0.22% | 893,000 -3.77% | 928,000 +24.73% | 744,000 -33.27% | |
Total Operating Expenses | 224.3M -22.57% | 289.7M +2.59% | 282.4M +52.27% | 185.5M +44.21% | |
Operating Profit | -214.6M +38.87% | -154.6M -19.09% | -191.0M +45.21% | -131.6M -282.78% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 13.8M -46.12% | 25.6M -16.12% | 30.6M +413.37% | 6.0M +11,122.22% | |
Income before Taxes | -200.8M +55.77% | -128.9M -19.66% | -160.5M +27.77% | -125.6M -274.64% | |
Income Taxes | 43.3M +753.52% | -6.6M -50.79% | -13.5M +55.41% | -8.7M -275.01% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -244.1M +99.57% | -122.3M -16.81% | -147.0M +25.72% | -116.9M -274.62% | |
Net Income from Continuing Operations Applicable to Common | -200.8M +55.77% | -128.9M -19.66% | -160.5M +27.77% | -125.6M -274.64% | |
Basic EPS and Net Income | -4.53 +99.56% | -2.27 -17.75% | -2.76 +11.74% | -2.47 -263.58% | |
Diluted EPS and Net Income | -4.53 +99.56% | -2.27 -17.75% | -2.76 +11.74% | -2.47 -278.99% | |
Basic Weighted Average Shares | 53.8M +0.11% | 53.8M +1.04% | 53.2M +12.34% | 47.4M +7.10% | |
Diluted Weighted Average Shares | 53.8M +0.11% | 53.8M +1.04% | 53.2M +12.34% | 47.4M -2.26% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 307.5M -34.76% | 471.4M -23.83% | 618.8M -12.89% | 710.4M +22.68% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 307.5M -34.76% | 471.4M -23.83% | 618.8M -12.89% | 710.4M +22.68% | |
Total Current Assets | 315.2M -35.07% | 485.4M -24.07% | 639.3M -11.10% | 719.1M +22.96% | |
Accumulated Depreciation | 7.1M -15.12% | 8.3M +12.04% | 7.4M -33.60% | 11.2M +6.76% | |
Property and Plant and Equipment and Net | 2.1M -30.41% | 3.1M -19.68% | 3.8M +121.61% | 1.7M -13.97% | |
Total Long-Term Assets | 11.6M -81.18% | 61.7M +8.05% | 57.1M +46.65% | 38.9M +58.56% | |
Total Assets | 326.8M -40.27% | 547.1M -21.44% | 696.4M -8.13% | 758.0M +24.40% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 40.8M -15.79% | 48.5M -14.75% | 56.9M +13.45% | 50.1M +49.91% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 5.5M -53.03% | 11.7M -85.05% | 78.1M -8.99% | 85.8M -21.87% | |
Total Liabilities | 46.3M -23.02% | 60.2M -55.43% | 135.0M -0.72% | 136.0M -5.11% | |
Retained Earnings | -1.3B +22.14% | -1.1B +12.48% | -980.0M +17.65% | -833.0M +16.33% | |
Total Stockholders Equity | 280.5M -42.40% | 486.9M -13.26% | 561.4M -9.75% | 622.0M +33.47% | |
Total Shares Outstanding | 53.8M +0.01% | 53.8M +0.27% | 53.7M +3.03% | 52.1M +11.67% | |
Cash Flow | |||||
Cash from Operating Activities | -163.6M +9.02% | -150.1M +12.06% | -133.9M +23.05% | -108.8M -217.51% | |
Capital Expenditures | 138,000 -53.69% | 298,000 -89.40% | 2.8M +505.60% | 464,000 -19.30% | |
Cash from Investing Activities | -138,000 -53.69% | -298,000 -89.25% | -2.8M +497.63% | -464,000 -19.30% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -139,000 -108.94% | 1.6M -96.55% | 45.1M -81.32% | 241.5M +26.86% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -2,227.94% +1,848.24% | -114.36% -45.30% | -209.08% -14.33% | -244.05% -780.12% | |
Return on Assets | -55.86% +183.97% | -19.67% -2.70% | -20.22% +18.20% | -17.11% -220.34% | |
Return on Equity | -63.62% +172.62% | -23.34% -6.09% | -24.85% +15.59% | -21.50% -204.32% | |
Revenue Growth | -92.87% -293.80% | 47.92% -31.05% | 69.50% +195.05% | -73.12% -100.31% | |
Current Ratio | 7.72 -22.89% | 10.01 -10.93% | 11.24 -21.64% | 14.34 -17.97% | |
Cash Ratio | 7.53 -22.53% | 9.72 -10.65% | 10.88 -23.22% | 14.17 -18.17% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow